RSA - ACTIS Hip Stem

Hip Osteoarthritis Clinical Trial

Official title:

Roentgen Stereophotogrammetric Analysis (RSA): ACTIS Hip Stem

Clinical Trial Details — Status: Active, not recruiting

Administrative data

• NCT number: NCT04879732
• Other study ID #: B2021:005
• Status: Active, not recruiting
• Phase: N/A
• Start date: October 5, 2021
• Est. completion date: December 31, 2024

Study information

• Verified date: December 2023
• Source: Canadian Radiostereometric Analysis Network
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The principal objective of this study is to compare mean 2-year subsidence of the ACTIS femoral stem using model-based RSA against published migration patterns for hip stems of a similar design. Secondary objectives include comparison of migration per surgical approach, quantifying changes in functional and health status of subjects following surgery, and assess occurrences of complications and adverse events.

Description:

This is a multi-centre, sequential enrollment trial of patients undergoing primary total hip arthroplasty. Patients will be recruited at three Canadian Centres to receive the ACTIS femoral hip stem via 3 different surgical approaches. Model-based RSA will identify migration of the implant with respect to the femoral bone during the first 2 post-operative years. Patient health and functional outcomes will be recorded at pre- and post-operative intervals to quantify improvement as a result of the surgery and trajectory of recovery. Adverse events and clinical complications in each study group will be captured and compared. Select surgical, hospital and rehabilitation data will be collected to measure health economic outcomes relating to the surgery.

Recruitment information / eligibility

• Status: Active, not recruiting
• Enrollment: 64
• Est. completion date: December 31, 2024
• Est. primary completion date: December 31, 2024
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 21 Years and older

Eligibility

Inclusion Criteria:

• Symptomatic osteoarthritis of the hip indicating primary total hip arthroplasty
• Aged 21 years or older
• Patients willing and able to comply with follow-up requirements and self-evaluations
• Ability to give informed consent
• Body mass index =45 kg/m2 Exclusion Criteria
• Active or prior infection
• Medical condition precluding major surgery
• Medical condition with less than 2 years life expectancy
• Overhanging pannus (for anterior approach cohort only)
• Prior surgery of the hip involving implantation of hardware (i.e., hemiarthroplasty, internal fixation, pelvic reconstruction near the acetabulum requiring removal)
• Skin condition on the area of incision
• Multi-level lumbar spine fusion
• Ankylosing spondylolithesis
• Shortening osteotomy through the femur

Related Conditions & MeSH terms

• Hip Osteoarthritis
• Osteoarthritis, Hip

Intervention

Device:
• ACTIS
ACTIS Hip stem

Locations

Country	Name	City	State
Canada	Nova Scotia Health - Orthopedic	Halifax	Nova Scotia
Canada	London Health Sciences Centre	London	Ontario
Canada	Orthopaedic Innovation Centre	Winnipeg	Manitoba

Sponsors (2)

Lead Sponsor	Collaborator
Canadian Radiostereometric Analysis Network	DePuy Synthes

Country where clinical trial is conducted

Canada, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Subsidence of the ACTIS femoral stem	Compare mean 2-year subsidence using model-based RSA (radiostereometric analysis) (mm). The images taken at each time point will be compared with the baseline to assess the change in implant position.	2 Year
Secondary	Comparison of migration per surgical approach	Comparison between the 3 approaches (postero-lateral, direct lateral, and direct anterior); measured migration (mm). The images taken at each time point will be compared with the baseline to assess implant migration. Therefore the outcome is change in implant position measured using RSA.	2 Year
Secondary	Oxford Hip Score (OHS)	Evaluate and compare the change from preoperative to 2 years between the study groups timepoints in functional outcomes assessments, patient reported outcome. Each item is scored from 0 to 4, and the items are summated, with lower total scores indicating poorer performance.	Preoperative, 6 Weeks, 3 Months, 6 Months, 1 Year and 2 Years
Secondary	Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC)	Evaluate and compare the change from preoperative to 2 years between the study groups and timepoints. The scores in each section (pain, stiffness and function limitation) are totaled; 5 items for pain (score range 0-20), 2 for stiffness (score range 0-8), and 17 for functional limitation (score range 0-68). Higher scores on the WOMAC indicate worse pain, stiffness, and functional limitations.	Preoperative, 6 Weeks, 3 Months, 6 Months, 1 Year and 2 Years
Secondary	European Quality of Life (EQ-5D-5L) questionnaire	Evaluate and compare the change from preoperative to 2 years between the study groups timepoints in functional outcomes assessments, patient reported outcome. A health state score is obtained based on the responses from 1-5 in each subscale, from which a single index value is calculated representing patients' overall health state. The overall health state range from 0 to 1.0.	Preoperative, 6 Weeks, 3 Months, 6 Months, 1 Year and 2 Years
Secondary	Visual analogue scale (VAS) for thigh pain	Evaluate and compare the change from preoperative to 2 years between the study groups timepoints in patient reported satisfaction as measured using the visual analogue scale (VAS) from 0 (No pain) - 100 (Worst pain imaginable).	Preoperative, 6 Weeks, 3 Months, 6 Months, 1 Year and 2 Years
Secondary	Visual analogue scale (VAS) for satisfaction	Evaluate and compare the change from preoperative to 2 years between the study groups timepoints in patient reported pain severity as measured using the visual analogue scale (VAS) from 0 (Unsatisfied) - 100 (Completely satisfied).	Preoperative, 6 Weeks, 3 Months, 6 Months, 1 Year and 2 Years
Secondary	University of California at Los Angeles (UCLA) Activity Level scale	Evaluate and compare the change in UCLA activity score compared to baseline in the study cohort. UCLA activity scores range from 1 to 10, and is a measure of activity with 10 being most active.	Preoperative, 6 Weeks, 3 Months, 6 Months, 1 Year and 2 Years